vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and WORKIVA INC (WK). Click either name above to swap in a different company.
WORKIVA INC is the larger business by last-quarter revenue ($238.9M vs $208.9M, roughly 1.1× iRhythm Holdings, Inc.). WORKIVA INC runs the higher net margin — 4.9% vs 2.7%, a 2.3% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 19.5%). WORKIVA INC produced more free cash flow last quarter ($50.7M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 16.6%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Workiva, Inc. is a global software-as-a-service (SaaS) company. It provides a cloud-based connected and reporting compliance platform that enables the use of connected data and automation of reporting across finance, accounting, risk, and compliance.
IRTC vs WK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $238.9M |
| Net Profit | $5.6M | $11.8M |
| Gross Margin | 70.9% | 80.7% |
| Operating Margin | 1.1% | 3.3% |
| Net Margin | 2.7% | 4.9% |
| Revenue YoY | 27.1% | 19.5% |
| Net Profit YoY | 518.5% | 234.0% |
| EPS (diluted) | $0.18 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $238.9M | ||
| Q3 25 | $192.9M | $224.2M | ||
| Q2 25 | $186.7M | $215.2M | ||
| Q1 25 | $158.7M | $206.3M | ||
| Q4 24 | $164.3M | $199.9M | ||
| Q3 24 | $147.5M | $185.6M | ||
| Q2 24 | $148.0M | $177.5M | ||
| Q1 24 | $131.9M | $175.7M |
| Q4 25 | $5.6M | $11.8M | ||
| Q3 25 | $-5.2M | $2.8M | ||
| Q2 25 | $-14.2M | $-19.4M | ||
| Q1 25 | $-30.7M | $-21.4M | ||
| Q4 24 | $-1.3M | $-8.8M | ||
| Q3 24 | $-46.2M | $-17.0M | ||
| Q2 24 | $-20.1M | $-17.5M | ||
| Q1 24 | $-45.7M | $-11.7M |
| Q4 25 | 70.9% | 80.7% | ||
| Q3 25 | 71.1% | 79.3% | ||
| Q2 25 | 71.2% | 77.0% | ||
| Q1 25 | 68.8% | 76.6% | ||
| Q4 24 | 70.0% | 77.1% | ||
| Q3 24 | 68.8% | 76.5% | ||
| Q2 24 | 69.9% | 76.8% | ||
| Q1 24 | 66.3% | 76.4% |
| Q4 25 | 1.1% | 3.3% | ||
| Q3 25 | -4.4% | -1.5% | ||
| Q2 25 | -10.0% | -10.3% | ||
| Q1 25 | -20.5% | -12.0% | ||
| Q4 24 | -2.5% | -6.7% | ||
| Q3 24 | -34.1% | -11.7% | ||
| Q2 24 | -15.5% | -13.0% | ||
| Q1 24 | -28.9% | -10.4% |
| Q4 25 | 2.7% | 4.9% | ||
| Q3 25 | -2.7% | 1.2% | ||
| Q2 25 | -7.6% | -9.0% | ||
| Q1 25 | -19.3% | -10.4% | ||
| Q4 24 | -0.8% | -4.4% | ||
| Q3 24 | -31.3% | -9.2% | ||
| Q2 24 | -13.6% | -9.9% | ||
| Q1 24 | -34.6% | -6.7% |
| Q4 25 | $0.18 | $0.21 | ||
| Q3 25 | $-0.16 | $0.05 | ||
| Q2 25 | $-0.44 | $-0.35 | ||
| Q1 25 | $-0.97 | $-0.38 | ||
| Q4 24 | $-0.03 | $-0.15 | ||
| Q3 24 | $-1.48 | $-0.31 | ||
| Q2 24 | $-0.65 | $-0.32 | ||
| Q1 24 | $-1.47 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $338.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $-5.4M |
| Total Assets | $1.0B | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $338.8M | ||
| Q3 25 | $565.2M | $315.9M | ||
| Q2 25 | $545.5M | $284.3M | ||
| Q1 25 | $520.6M | $242.0M | ||
| Q4 24 | $535.6M | $301.8M | ||
| Q3 24 | $522.0M | $248.2M | ||
| Q2 24 | $561.5M | $267.9M | ||
| Q1 24 | $569.1M | $296.1M |
| Q4 25 | $152.7M | $-5.4M | ||
| Q3 25 | $121.9M | $-36.9M | ||
| Q2 25 | $103.7M | $-66.5M | ||
| Q1 25 | $86.7M | $-75.7M | ||
| Q4 24 | $90.9M | $-41.7M | ||
| Q3 24 | $71.8M | $-50.8M | ||
| Q2 24 | $99.2M | $-77.7M | ||
| Q1 24 | $90.3M | $-83.2M |
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $995.2M | $1.4B | ||
| Q2 25 | $964.0M | $1.3B | ||
| Q1 25 | $926.1M | $1.3B | ||
| Q4 24 | $931.4M | $1.4B | ||
| Q3 24 | $909.7M | $1.3B | ||
| Q2 24 | $919.2M | $1.2B | ||
| Q1 24 | $909.8M | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $51.0M |
| Free Cash FlowOCF − Capex | $14.5M | $50.7M |
| FCF MarginFCF / Revenue | 6.9% | 21.2% |
| Capex IntensityCapex / Revenue | 5.6% | 0.1% |
| Cash ConversionOCF / Net Profit | 4.70× | 4.31× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $138.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $51.0M | ||
| Q3 25 | $34.9M | $46.2M | ||
| Q2 25 | $27.7M | $50.3M | ||
| Q1 25 | $-7.9M | $-7.4M | ||
| Q4 24 | $19.2M | $44.0M | ||
| Q3 24 | $24.3M | $18.9M | ||
| Q2 24 | $11.8M | $-14.0K | ||
| Q1 24 | $-52.0M | $24.8M |
| Q4 25 | $14.5M | $50.7M | ||
| Q3 25 | $20.1M | $46.1M | ||
| Q2 25 | $17.3M | $49.3M | ||
| Q1 25 | $-17.3M | $-8.1M | ||
| Q4 24 | $12.4M | $43.2M | ||
| Q3 24 | $15.5M | $18.7M | ||
| Q2 24 | $3.4M | $-122.0K | ||
| Q1 24 | $-61.8M | $24.6M |
| Q4 25 | 6.9% | 21.2% | ||
| Q3 25 | 10.4% | 20.5% | ||
| Q2 25 | 9.3% | 22.9% | ||
| Q1 25 | -10.9% | -3.9% | ||
| Q4 24 | 7.5% | 21.6% | ||
| Q3 24 | 10.5% | 10.1% | ||
| Q2 24 | 2.3% | -0.1% | ||
| Q1 24 | -46.8% | 14.0% |
| Q4 25 | 5.6% | 0.1% | ||
| Q3 25 | 7.7% | 0.0% | ||
| Q2 25 | 5.6% | 0.5% | ||
| Q1 25 | 5.9% | 0.4% | ||
| Q4 24 | 4.2% | 0.4% | ||
| Q3 24 | 6.0% | 0.1% | ||
| Q2 24 | 5.7% | 0.1% | ||
| Q1 24 | 7.4% | 0.1% |
| Q4 25 | 4.70× | 4.31× | ||
| Q3 25 | — | 16.57× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
WK
| License And Service | $219.3M | 92% |
| XBRL Professional Services | $16.4M | 7% |
| Other Services | $3.2M | 1% |
